Allocetra: Off-The-Shelf, Universal, Macrophage Reprogramming Cell Therapy for Life-Threatening Diseases

Time: 2:30 pm
day: Day Two Track A PM

Details:

  • Product description and mechanism of action
  • Preclinical and clinical efficacy results – inflammatory indications
  • Preclinical efficacy results in solid tumor models

Speakers: